ID   ERBB4_HUMAN             Reviewed;        1282 AA.
AC   Q15303-4;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-OCT-2022, entry version 235.
DE   RecName: Full=Isoform JM-B CYT-2 of Receptor tyrosine-protein kinase erbB-4;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene-like protein c-ErbB-4;
DE   AltName: Full=Tyrosine kinase-type cell surface receptor HER4;
DE   AltName: Full=p180erbB4;
DE   Contains:
DE     RecName: Full=ERBB4 intracellular domain;
DE              Short=4ICD;
DE              Short=E4ICD;
DE     AltName: Full=s80HER4;
DE   Flags: Precursor;
GN   Name=ERBB4; Synonyms=HER4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM JM-A CYT-1), FUNCTION AS CELL SURFACE
RP   RECEPTOR, AUTOPHOSPHORYLATION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=8383326; DOI=10.1073/pnas.90.5.1746;
RA   Plowman G.D., Culouscou J.-M., Whitney G.S., Green J.M., Carlton G.W.,
RA   Foy L., Neubauer M.G., Shoyab M.;
RT   "Ligand-specific activation of HER4/p180erbB4, a fourth member of the
RT   epidermal growth factor receptor family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:1746-1750(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS JM-A CYT-1 AND JM-B CYT-1), TISSUE
RP   SPECIFICITY, FUNCTION AS CELL SURFACE RECEPTOR FOR NRG1 AND BTC,
RP   SUBCELLULAR LOCATION, AUTOPHOSPHORYLATION, AND PROTEOLYTIC PROCESSING.
RC   TISSUE=Fetal brain;
RX   PubMed=9334263; DOI=10.1074/jbc.272.42.26761;
RA   Elenius K., Corfas G., Paul S., Choi C.J., Rio C., Plowman G.D.,
RA   Klagsbrun M.;
RT   "A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific
RT   tissue distribution and differential processing in response to phorbol
RT   ester.";
RL   J. Biol. Chem. 272:26761-26768(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS JM-A CYT-1; JM-B CYT-1;
RP   JM-A CYT-2 AND JM-B CYT-2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 401-1308 (ISOFORM JM-A CYT-2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   INTERACTION WITH NRG1, AND AUTOPHOSPHORYLATION.
RX   PubMed=7689552; DOI=10.1016/s0021-9258(17)46636-1;
RA   Culouscou J.-M., Plowman G.D., Carlton G.W., Green J.M., Shoyab M.;
RT   "Characterization of a breast cancer cell differentiation factor that
RT   specifically activates the HER4/p180erbB4 receptor.";
RL   J. Biol. Chem. 268:18407-18410(1993).
RN   [6]
RP   INTERACTION WITH NRG1, AND AUTOPHOSPHORYLATION.
RX   PubMed=7902537; DOI=10.1038/366473a0;
RA   Plowman G.D., Green J.M., Culouscou J.M., Carlton G.W., Rothwell V.M.,
RA   Buckley S.;
RT   "Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.";
RL   Nature 366:473-475(1993).
RN   [7]
RP   FUNCTION AS NRG1 RECEPTOR IN REGULATION OF CELL PROLIFERATION, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, AUTOPHOSPHORYLATION, PHOSPHORYLATION AT
RP   TYR-1056; TYR-1188 AND TYR-1242, AND INTERACTION WITH EGFR; SHC1 AND
RP   PIK3R1.
RX   PubMed=8617750; DOI=10.1074/jbc.271.9.4813;
RA   Cohen B.D., Green J.M., Foy L., Fell H.P.;
RT   "HER4-mediated biological and biochemical properties in NIH 3T3 cells.
RT   Evidence for HER1-HER4 heterodimers.";
RL   J. Biol. Chem. 271:4813-4818(1996).
RN   [8]
RP   INTERACTION WITH BTC, AND AUTOPHOSPHORYLATION.
RX   PubMed=8570211;
RA   Riese D.J. II, Bermingham Y., van Raaij T.M., Buckley S., Plowman G.D.,
RA   Stern D.F.;
RT   "Betacellulin activates the epidermal growth factor receptor and erbB-4,
RT   and induces cellular response patterns distinct from those stimulated by
RT   epidermal growth factor or neuregulin-beta.";
RL   Oncogene 12:345-353(1996).
RN   [9]
RP   FUNCTION AS HBEGF RECEPTOR; IN CELL MIGRATION; CELL PROLIFERATION AND IN
RP   ACTIVATION OF PIK3R1, INTERACTION WITH HBEGF AND PIK3R1, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=9135143; DOI=10.1093/emboj/16.6.1268;
RA   Elenius K., Paul S., Allison G., Sun J., Klagsbrun M.;
RT   "Activation of HER4 by heparin-binding EGF-like growth factor stimulates
RT   chemotaxis but not proliferation.";
RL   EMBO J. 16:1268-1278(1997).
RN   [10]
RP   INTERACTION WITH NRG2, FUNCTION AS NRG2 RECEPTOR, AND PHOSPHORYLATION.
RX   PubMed=9168115; DOI=10.1038/387512a0;
RA   Carraway K.L. III, Weber J.L., Unger M.J., Ledesma J., Yu N., Gassmann M.,
RA   Lai C.;
RT   "Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.";
RL   Nature 387:512-516(1997).
RN   [11]
RP   INTERACTION WITH EREG, AND AUTOPHOSPHORYLATION.
RX   PubMed=9419975; DOI=10.1038/sj.onc.1201458;
RA   Komurasaki T., Toyoda H., Uchida D., Morimoto S.;
RT   "Epiregulin binds to epidermal growth factor receptor and ErbB-4 and
RT   induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-
RT   2, ErbB-3 and ErbB-4.";
RL   Oncogene 15:2841-2848(1997).
RN   [12]
RP   INTERACTION WITH NRG3, AND AUTOPHOSPHORYLATION.
RX   PubMed=9275162; DOI=10.1073/pnas.94.18.9562;
RA   Zhang D., Sliwkowski M.X., Mark M., Frantz G., Akita R., Sun Y., Hillan K.,
RA   Crowley C., Brush J., Godowski P.J.;
RT   "Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and
RT   activates ErbB4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:9562-9567(1997).
RN   [13]
RP   INTERACTION WITH GRB7.
RX   PubMed=9516479; DOI=10.1074/jbc.273.13.7717;
RA   Fiddes R.J., Campbell D.H., Janes P.W., Sivertsen S.P., Sasaki H.,
RA   Wallasch C., Daly R.J.;
RT   "Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals
RT   a novel target selectivity for erbB3.";
RL   J. Biol. Chem. 273:7717-7724(1998).
RN   [14]
RP   INTERACTION WITH ERBB2, AND FUNCTION IN ACTIVATION OF STAT5A.
RX   PubMed=10358079; DOI=10.1074/jbc.274.24.17209;
RA   Olayioye M.A., Beuvink I., Horsch K., Daly J.M., Hynes N.E.;
RT   "ErbB receptor-induced activation of stat transcription factors is mediated
RT   by Src tyrosine kinases.";
RL   J. Biol. Chem. 274:17209-17218(1999).
RN   [15]
RP   ALTERNATIVE SPLICING, FUNCTION IN PHOSPHORYLATION AND ACTIVATION OF PIK3R1,
RP   INTERACTION WITH NRG1 AND PIKR3R1, AUTOPHOSPHORYLATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10353604; DOI=10.1038/sj.onc.1202612;
RA   Elenius K., Choi C.J., Paul S., Santiestevan E., Nishi E., Klagsbrun M.;
RT   "Characterization of a naturally occurring ErbB4 isoform that does not bind
RT   or activate phosphatidyl inositol 3-kinase.";
RL   Oncogene 18:2607-2615(1999).
RN   [16]
RP   FUNCTION AS NRG4 RECEPTOR IN ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1 AND IN
RP   CELL PROLIFERATION, INTERACTION WITH NRG4, AND SUBCELLULAR LOCATION.
RX   PubMed=10348342; DOI=10.1038/sj.onc.1202631;
RA   Harari D., Tzahar E., Romano J., Shelly M., Pierce J.H., Andrews G.C.,
RA   Yarden Y.;
RT   "Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor
RT   tyrosine kinase.";
RL   Oncogene 18:2681-2689(1999).
RN   [17]
RP   FUNCTION AS NRG1 RECEPTOR IN CELL PROLIFERATION; MIGRATION; SURVIVAL AND IN
RP   PHOSPHORYLATION OF SHC1; ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=10722704; DOI=10.1074/jbc.275.12.8641;
RA   Kainulainen V., Sundvall M., Maatta J.A., Santiestevan E., Klagsbrun M.,
RA   Elenius K.;
RT   "A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase
RT   mediates proliferation but not survival or chemotaxis.";
RL   J. Biol. Chem. 275:8641-8649(2000).
RN   [18]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=10744726; DOI=10.1074/jbc.275.14.10379;
RA   Rio C., Buxbaum J.D., Peschon J.J., Corfas G.;
RT   "Tumor necrosis factor-alpha-converting enzyme is required for cleavage of
RT   erbB4/HER4.";
RL   J. Biol. Chem. 275:10379-10387(2000).
RN   [19]
RP   FUNCTION IN ACTIVATION OF AKT1; MAPK1/ERK2 AND MAPK3/ERK1, INTERACTION WITH
RP   PIK3R1; GRB2; SHC1; BTC; NRG1; NRG2 AND NRG3, AND LIGAND-SPECIFIC
RP   AUTOPHOSPHORYLATION.
RX   PubMed=10867024; DOI=10.1074/jbc.c901015199;
RA   Sweeney C., Lai C., Riese D.J. II, Diamonti A.J., Cantley L.C.,
RA   Carraway K.L. III;
RT   "Ligand discrimination in signaling through an ErbB4 receptor homodimer.";
RL   J. Biol. Chem. 275:19803-19807(2000).
RN   [20]
RP   INTERACTION WITH DLG2; DLG3; DLG4 AND SNTB2.
RX   PubMed=10725395; DOI=10.1073/pnas.97.7.3596;
RA   Garcia R.A., Vasudevan K., Buonanno A.;
RT   "The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at
RT   neuronal synapses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:3596-3601(2000).
RN   [21]
RP   FUNCTION AS NRG1 RECEPTOR AND IN ACTIVATION OF MAP KINASES,
RP   AUTOPHOSPHORYLATION, AND ACTIVITY REGULATION.
RX   PubMed=11178955; DOI=10.1006/bbrc.2001.4302;
RA   Egeblad M., Mortensen O.H., van Kempen L.C., Jaattela M.;
RT   "BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at
RT   different concentrations in intact cells.";
RL   Biochem. Biophys. Res. Commun. 281:25-31(2001).
RN   [22]
RP   MUTAGENESIS OF LYS-751, AND FUNCTION IN PROMOTING CELL DIFFERENTIATION AND
RP   INHIBITING CELL PROLIFERATION.
RX   PubMed=11390655; DOI=10.1128/mcb.21.13.4265-4275.2001;
RA   Sartor C.I., Zhou H., Kozlowska E., Guttridge K., Kawata E., Caskey L.,
RA   Harrelson J., Hynes N., Ethier S., Calvo B., Earp H.S. III;
RT   "Her4 mediates ligand-dependent antiproliferative and differentiation
RT   responses in human breast cancer cells.";
RL   Mol. Cell. Biol. 21:4265-4275(2001).
RN   [23]
RP   FUNCTION, PROTEOLYTIC PROCESSING, SUBCELLULAR LOCATION, INTERACTION WITH
RP   YAP1, AND MUTAGENESIS OF TYR-1301.
RX   PubMed=12807903; DOI=10.1074/jbc.m305597200;
RA   Komuro A., Nagai M., Navin N.E., Sudol M.;
RT   "WW domain-containing protein YAP associates with ErbB-4 and acts as a co-
RT   transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that
RT   translocates to the nucleus.";
RL   J. Biol. Chem. 278:33334-33341(2003).
RN   [24]
RP   INTERACTION WITH MUC1.
RX   PubMed=12939402;
RA   Li Y., Yu W.-H., Ren J., Chen W., Huang L., Kharbanda S., Loda M., Kufe D.;
RT   "Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent
RT   on the DF3/MUC1 oncoprotein.";
RL   Mol. Cancer Res. 1:765-775(2003).
RN   [25]
RP   INTERACTION WITH STAT5A, SUBCELLULAR LOCATION, FUNCTION IN NUCLEAR
RP   LOCALIZATION OF STAT5A, DNA-BINDING, AND MUTAGENESIS OF 681-LYS--ARG-684.
RX   PubMed=15534001; DOI=10.1083/jcb.200403155;
RA   Williams C.C., Allison J.G., Vidal G.A., Burow M.E., Beckman B.S.,
RA   Marrero L., Jones F.E.;
RT   "The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by
RT   functioning as a STAT5A nuclear chaperone.";
RL   J. Cell Biol. 167:469-478(2004).
RN   [26]
RP   INTERACTION WITH WWOX, DOMAIN, AND MUTAGENESIS OF TYR-1035 AND TYR-1301.
RX   PubMed=16061658; DOI=10.1158/0008-5472.can-05-1150;
RA   Aqeilan R.I., Donati V., Palamarchuk A., Trapasso F., Kaou M., Pekarsky Y.,
RA   Sudol M., Croce C.M.;
RT   "WW domain-containing proteins, WWOX and YAP, compete for interaction with
RT   ErbB-4 and modulate its transcriptional function.";
RL   Cancer Res. 65:6764-6772(2005).
RN   [27]
RP   FUNCTION, PROTEOLYTIC PROCESSING, AND MUTAGENESIS OF VAL-675.
RX   PubMed=15746097; DOI=10.1074/jbc.m412457200;
RA   Vidal G.A., Naresh A., Marrero L., Jones F.E.;
RT   "Presenilin-dependent gamma-secretase processing regulates multiple
RT   ERBB4/HER4 activities.";
RL   J. Biol. Chem. 280:19777-19783(2005).
RN   [28]
RP   FUNCTION IN PROMOTING APOPTOSIS, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   BCL2.
RX   PubMed=16778220; DOI=10.1158/0008-5472.can-05-2368;
RA   Naresh A., Long W., Vidal G.A., Wimley W.C., Marrero L., Sartor C.I.,
RA   Tovey S., Cooke T.G., Bartlett J.M., Jones F.E.;
RT   "The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting
RT   apoptosis of breast cancer cells.";
RL   Cancer Res. 66:6412-6420(2006).
RN   [29]
RP   INTERACTION WITH CBFA2T3.
RX   PubMed=16815842; DOI=10.1074/jbc.m603998200;
RA   Linggi B., Carpenter G.;
RT   "ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional
RT   repression.";
RL   J. Biol. Chem. 281:25373-25380(2006).
RN   [30]
RP   FUNCTION, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=16251361; DOI=10.1091/mbc.e05-05-0402;
RA   Maatta J.A., Sundvall M., Junttila T.T., Peri L., Laine V.J., Isola J.,
RA   Egeblad M., Elenius K.;
RT   "Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4
RT   isoform promote ligand-independent survival and cancer cell growth.";
RL   Mol. Biol. Cell 17:67-79(2006).
RN   [31]
RP   FUNCTION IN DIFFERENTIATION OF MAMMARY EPITHELIUM, PROTEOLYTIC PROCESSING,
RP   AUTOPHOSPHORYLATION, SUBCELLULAR LOCATION, AND INTERACTION WITH STAT5A.
RX   PubMed=16837552; DOI=10.1091/mbc.e06-02-0101;
RA   Muraoka-Cook R.S., Sandahl M., Husted C., Hunter D., Miraglia L.,
RA   Feng S.M., Elenius K., Earp H.S. III;
RT   "The intracellular domain of ErbB4 induces differentiation of mammary
RT   epithelial cells.";
RL   Mol. Biol. Cell 17:4118-4129(2006).
RN   [32]
RP   MUTAGENESIS OF GLN-646, AND PHOSPHORYLATION AT TYR-1056.
RX   PubMed=17120616; DOI=10.3727/000000006783981134;
RA   Pitfield S.E., Bryant I., Penington D.J., Park G., Riese D.J. II;
RT   "Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling
RT   to inhibition of colony formation by human mammary cell lines.";
RL   Oncol. Res. 16:179-193(2006).
RN   [33]
RP   FUNCTION OF ERBB4 INTRACELLULAR DOMAIN, PROTEOLYTIC PROCESSING, SUBCELLULAR
RP   LOCATION, UBIQUITINATION OF ERBB4 INTRACELLULAR DOMAIN, AND MUTAGENESIS OF
RP   VAL-675; LYS-751; ARG-992; LEU-995 AND ASP-1000.
RX   PubMed=17638867; DOI=10.1158/0008-5472.can-06-4145;
RA   Strunk K.E., Husted C., Miraglia L.C., Sandahl M., Rearick W.A.,
RA   Hunter D.M., Earp H.S. III, Muraoka-Cook R.S.;
RT   "HER4 D-box sequences regulate mitotic progression and degradation of the
RT   nuclear HER4 cleavage product s80HER4.";
RL   Cancer Res. 67:6582-6590(2007).
RN   [34]
RP   INTERACTION WITH ERBB2, MUTAGENESIS OF ASP-843, AND AUTOPHOSPHORYLATION IN
RP   TRANS.
RX   PubMed=16978839; DOI=10.1016/j.cellsig.2006.07.020;
RA   Li Z., Mei Y., Liu X., Zhou M.;
RT   "Neuregulin-1 only induces trans-phosphorylation between ErbB receptor
RT   heterodimer partners.";
RL   Cell. Signal. 19:466-471(2007).
RN   [35]
RP   FUNCTION OF E4ICD, PHOSPHORYLATION, SUBCELLULAR LOCATION OF E4ICD, AND
RP   MUTAGENESIS OF LYS-751.
RX   PubMed=17486069; DOI=10.1038/sj.onc.1210501;
RA   Sundvall M., Peri L., Maatta J.A., Tvorogov D., Paatero I., Savisalo M.,
RA   Silvennoinen O., Yarden Y., Elenius K.;
RT   "Differential nuclear localization and kinase activity of alternative ErbB4
RT   intracellular domains.";
RL   Oncogene 26:6905-6914(2007).
RN   [36]
RP   PHOSPHORYLATION AT TYR-875; TYR-1035; TYR-1056; TYR-1150; TYR-1162;
RP   TYR-1188; TYR-1202; TYR-1242; TYR-1258 AND TYR-1284, INTERACTION WITH
RP   PIK3R1 AND STAT1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18721752; DOI=10.1016/j.chembiol.2008.07.006;
RA   Kaushansky A., Gordus A., Budnik B.A., Lane W.S., Rush J., MacBeath G.;
RT   "System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation
RT   that are unusually selective in their recruitment properties.";
RL   Chem. Biol. 15:808-817(2008).
RN   [37]
RP   INTERACTION WITH NEDD4, SUBCELLULAR LOCATION, AND UBIQUITINATION OF E4ICD1.
RX   PubMed=19193720; DOI=10.1096/fj.08-121947;
RA   Zeng F., Xu J., Harris R.C.;
RT   "Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK
RT   II cells.";
RL   FASEB J. 23:1935-1945(2009).
RN   [38]
RP   FUNCTION IN ACTIVATION OF SIGNALING PATHWAYS, INTERACTION WITH ERBB2,
RP   CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION, PHOSPHORYLATION BY ERBB2, ACTIVITY
RP   REGULATION, AND MUTAGENESIS OF VAL-721; ALA-773; ARG-782; GLU-810; PRO-854;
RP   ASP-861; GLU-872 AND THR-926.
RX   PubMed=19098003; DOI=10.1074/jbc.m805438200;
RA   Tvorogov D., Sundvall M., Kurppa K., Hollmen M., Repo S., Johnson M.S.,
RA   Elenius K.;
RT   "Somatic mutations of ErbB4: selective loss-of-function phenotype affecting
RT   signal transduction pathways in cancer.";
RL   J. Biol. Chem. 284:5582-5591(2009).
RN   [39]
RP   INTERACTION WITH WWP1, AND MUTAGENESIS OF TYR-1056 AND TYR-1301.
RX   PubMed=19561640; DOI=10.1038/onc.2009.162;
RA   Li Y., Zhou Z., Alimandi M., Chen C.;
RT   "WW domain containing E3 ubiquitin protein ligase 1 targets the full-length
RT   ErbB4 for ubiquitin-mediated degradation in breast cancer.";
RL   Oncogene 28:2948-2958(2009).
RN   [40]
RP   INTERACTION WITH TXNL4A; DDX23; MATR3; RBM15; ILF3; TRIM28; U5S1; U2SURP;
RP   ITCH; HNRNPU; AP2A1; NULC; LEO1; WWP2; MDM2; HXK1 AND SRRT, FUNCTION,
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20858735; DOI=10.1158/1541-7786.mcr-10-0042;
RA   Gilmore-Hebert M., Ramabhadran R., Stern D.F.;
RT   "Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage
RT   response pathways.";
RL   Mol. Cancer Res. 8:1388-1398(2010).
RN   [41]
RP   ACTIVITY REGULATION.
RX   PubMed=21439954; DOI=10.1016/j.yexcr.2011.03.015;
RA   Carrasco-Garcia E., Saceda M., Grasso S., Rocamora-Reverte L., Conde M.,
RA   Gomez-Martinez A., Garcia-Morales P., Ferragut J.A., Martinez-Lacaci I.;
RT   "Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting
RT   with erbB3 and erbB4 in glioblastoma cell lines.";
RL   Exp. Cell Res. 317:1476-1489(2011).
RN   [42]
RP   REVIEW ON ROLE IN BREAST AND NEURAL DEVELOPMENT.
RX   PubMed=14504474;
RA   Jones F.E., Golding J.P., Gassmann M.;
RT   "ErbB4 signaling during breast and neural development: novel genetic models
RT   reveal unique ErbB4 activities.";
RL   Cell Cycle 2:555-559(2003).
RN   [43]
RP   REVIEW.
RX   PubMed=15944951; DOI=10.14670/hh-20.1005;
RA   Zaczek A., Brandt B., Bielawski K.P.;
RT   "The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase
RT   receptors and the consequences for therapeutic approaches.";
RL   Histol. Histopathol. 20:1005-1015(2005).
RN   [44]
RP   REVIEW ON ROLE IN MAMMARY GLAND DEVELOPMENT.
RX   PubMed=18437540; DOI=10.1007/s10911-008-9080-x;
RA   Muraoka-Cook R.S., Feng S.M., Strunk K.E., Earp H.S. III;
RT   "ErbB4/HER4: role in mammary gland development, differentiation and growth
RT   inhibition.";
RL   J. Mammary Gland Biol. Neoplasia 13:235-246(2008).
RN   [45]
RP   REVIEW ON ROLE OF THE ERBB4 INTRACELLULAR DOMAIN.
RX   PubMed=18473151; DOI=10.1007/s10911-008-9076-6;
RA   Jones F.E.;
RT   "HER4 intracellular domain (4ICD) activity in the developing mammary gland
RT   and breast cancer.";
RL   J. Mammary Gland Biol. Neoplasia 13:247-258(2008).
RN   [46]
RP   REVIEW ON LIGAND SPECIFICITY AND SIGNALING.
RX   PubMed=18454307; DOI=10.1007/s10911-008-9079-3;
RA   Sundvall M., Iljin K., Kilpinen S., Sara H., Kallioniemi O.P., Elenius K.;
RT   "Role of ErbB4 in breast cancer.";
RL   J. Mammary Gland Biol. Neoplasia 13:259-268(2008).
RN   [47]
RP   REVIEW ON ROLE IN NRG1 SIGNALING AND CARDIOVASCULAR HEALTH.
RX   PubMed=20933198; DOI=10.1016/s1054-3589(10)59002-1;
RA   Xu Y., Li X., Liu X., Zhou M.;
RT   "Neuregulin-1/ErbB signaling and chronic heart failure.";
RL   Adv. Pharmacol. 59:31-51(2010).
RN   [48]
RP   REVIEW ON ALTERNATIVE SPLICING AND PROTEOLYTIC PROCESSING; TISSUE
RP   SPECIFICITY; SIGNALING AND ROLE IN DISEASE.
RX   PubMed=21811097; DOI=10.4161/cc.10.16.17194;
RA   Veikkolainen V., Vaparanta K., Halkilahti K., Iljin K., Sundvall M.,
RA   Elenius K.;
RT   "Function of ERBB4 is determined by alternative splicing.";
RL   Cell Cycle 10:2647-2657(2011).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 26-641, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-138; ASN-174; ASN-253; ASN-358; ASN-410; ASN-473;
RP   ASN-495 AND ASN-576.
RX   PubMed=16203964; DOI=10.1073/pnas.0507591102;
RA   Bouyain S., Longo P.A., Li S., Ferguson K.M., Leahy D.J.;
RT   "The extracellular region of ErbB4 adopts a tethered conformation in the
RT   absence of ligand.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:15024-15029(2005).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 690-999 IN COMPLEX WITH INHIBITOR,
RP   CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LEU-710;
RP   MET-766; LEU-864 AND ILE-947.
RX   PubMed=18287036; DOI=10.1073/pnas.0708281105;
RA   Wood E.R., Shewchuk L.M., Ellis B., Brignola P., Brashear R.L.,
RA   Caferro T.R., Dickerson S.H., Dickson H.D., Donaldson K.H., Gaul M.,
RA   Griffin R.J., Hassell A.M., Keith B., Mullin R., Petrov K.G., Reno M.J.,
RA   Rusnak D.W., Tadepalli S.M., Ulrich J.C., Wagner C.D., Vanderwall D.E.,
RA   Waterson A.G., Williams J.D., White W.L., Uehling D.E.;
RT   "6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as
RT   tunable covalent modifiers of ErbB kinases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2773-2778(2008).
RN   [51]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 702-1029 OF APOPROTEIN AND IN
RP   COMPLEX WITH LAPATINIB, CATALYTIC ACTIVITY, ACTIVITY REGULATION,
RP   AUTOPHOSPHORYLATION, AND SUBUNIT.
RX   PubMed=18334220; DOI=10.1016/j.str.2007.12.016;
RA   Qiu C., Tarrant M.K., Choi S.H., Sathyamurthy A., Bose R., Banjade S.,
RA   Pal A., Bornmann W.G., Lemmon M.A., Cole P.A., Leahy D.J.;
RT   "Mechanism of activation and inhibition of the HER4/ErbB4 kinase.";
RL   Structure 16:460-467(2008).
RN   [52]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-140 AND TYR-303.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [53]
RP   VARIANTS ALS19 GLN-927 AND TRP-1275, AND CHARACTERIZATION OF VARIANTS ASL19
RP   GLN-927 AND TRP-1275.
RX   PubMed=24119685; DOI=10.1016/j.ajhg.2013.09.008;
RA   Takahashi Y., Fukuda Y., Yoshimura J., Toyoda A., Kurppa K., Moritoyo H.,
RA   Belzil V.V., Dion P.A., Higasa K., Doi K., Ishiura H., Mitsui J., Date H.,
RA   Ahsan B., Matsukawa T., Ichikawa Y., Moritoyo T., Ikoma M., Hashimoto T.,
RA   Kimura F., Murayama S., Onodera O., Nishizawa M., Yoshida M., Atsuta N.,
RA   Sobue G., Fifita J.A., Williams K.L., Blair I.P., Nicholson G.A.,
RA   Gonzalez-Perez P., Brown R.H. Jr., Nomoto M., Elenius K., Rouleau G.A.,
RA   Fujiyama A., Morishita S., Goto J., Tsuji S., Nakamura R., Watanabe H.,
RA   Izumi Y., Kaji R., Morita M., Ogaki K., Taniguchi A., Aiba I.,
RA   Mizoguchi K., Okamoto K., Hasegawa K., Aoki M., Kawata A., Nakano I.,
RA   Abe K., Oda M., Konagaya M., Imai T., Nakagawa M., Fujita T., Sasaki H.,
RA   Nishizawa M.;
RT   "ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause
RT   amyotrophic lateral sclerosis type 19.";
RL   Am. J. Hum. Genet. 93:900-905(2013).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=JM-A CYT-1;
CC         IsoId=Q15303-1; Sequence=Displayed;
CC       Name=JM-B CYT-1;
CC         IsoId=Q15303-2; Sequence=VSP_002895;
CC       Name=JM-A CYT-2;
CC         IsoId=Q15303-3; Sequence=VSP_022148;
CC       Name=JM-B CYT-2;
CC         IsoId=Q15303-4; Sequence=VSP_002895, VSP_022148;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   RefSeq; XP_005246434.1; XM_005246377.2.
DR   ProteomicsDB; 60523; -.
DR   Proteomes; UP000005640; Chromosome 2.
PE   1: Evidence at protein level;
SQ   SEQUENCE   1282 AA;  143968 MW;  68F27777BC9E2F74 CRC64;
     MKPATGLWVW VSLLVAAGTV QPSDSQSVCA GTENKLSSLS DLEQQYRALR KYYENCEVVM
     GNLEITSIEH NRDLSFLRSV REVTGYVLVA LNQFRYLPLE NLRIIRGTKL YEDRYALAIF
     LNYRKDGNFG LQELGLKNLT EILNGGVYVD QNKFLCYADT IHWQDIVRNP WPSNLTLVST
     NGSSGCGRCH KSCTGRCWGP TENHCQTLTR TVCAEQCDGR CYGPYVSDCC HRECAGGCSG
     PKDTDCFACM NFNDSGACVT QCPQTFVYNP TTFQLEHNFN AKYTYGAFCV KKCPHNFVVD
     SSSCVRACPS SKMEVEENGI KMCKPCTDIC PKACDGIGTG SLMSAQTVDS SNIDKFINCT
     KINGNLIFLV TGIHGDPYNA IEAIDPEKLN VFRTVREITG FLNIQSWPPN MTDFSVFSNL
     VTIGGRVLYS GLSLLILKQQ GITSLQFQSL KEISAGNIYI TDNSNLCYYH TINWTTLFST
     INQRIVIRDN RKAENCTAEG MVCNHLCSSD GCWGPGPDQC LSCRRFSRGR ICIESCNLYD
     GEFREFENGS ICVECDPQCE KMEDGLLTCH GPGPDNCTKC SHFKDGPNCV EKCPDGLQGA
     NSFIFKYADP DRECHPCHPN CTQGCIGSSI EDCIGLMDRT PLIAAGVIGG LFILVIVGLT
     FAVYVRRKSI KKKRALRRFL ETELVEPLTP SGTAPNQAQL RILKETELKR VKVLGSGAFG
     TVYKGIWVPE GETVKIPVAI KILNETTGPK ANVEFMDEAL IMASMDHPHL VRLLGVCLSP
     TIQLVTQLMP HGCLLEYVHE HKDNIGSQLL LNWCVQIAKG MMYLEERRLV HRDLAARNVL
     VKSPNHVKIT DFGLARLLEG DEKEYNADGG KMPIKWMALE CIHYRKFTHQ SDVWSYGVTI
     WELMTFGGKP YDGIPTREIP DLLEKGERLP QPPICTIDVY MVMVKCWMID ADSRPKFKEL
     AAEFSRMARD PQRYLVIQGD DRMKLPSPND SKFFQNLLDE EDLEDMMDAE EYLVPQAFNI
     PPPIYTSRAR IDSNRNQFVY RDGGFAAEQG VSVPYRAPTS TIPEAPVAQG ATAEIFDDSC
     CNGTLRKPVA PHVQEDSSTQ RYSADPTVFA PERSPRGELD EEGYMTPMRD KPKQEYLNPV
     EENPFVSRRK NGDLQALDNP EYHNASNGPP KAEDEYVNEP LYLNTFANTL GKAEYLKNNI
     LSMPEKAKKA FDNPDYWNHS LPPRSTLQHP DYLQEYSTKY FYKQNGRIRP IVAENPEYLS
     EFSLKPGTVL PPPPYRHRNT VV
//
